Novel therapeutic targets for allergic airway disease in children

Drugs in Context
Alessandro GiallongoSalvatore Leonardi

Abstract

The aim of precision medicine is setting up targeted therapies for selected patients that would ideally have high effectiveness and few side effects. This is made possible by targeted therapy drugs that selectively act on a specific pathway. Precision medicine is spreading to many medical specialties, and there is increasing interest in the context of allergic airway diseases, such as allergic rhinitis, chronic rhinosinusitis, and asthma. This review is an update of new targets in the treatment of childhood allergic upper airway diseases and asthma, including the most recent biologic drugs that have already been licensed or are in the pipeline to be tested with children.

Citations

Aug 19, 2020·Expert Opinion on Pharmacotherapy·Peter Valentin Tomazic, Doris Lang-Loidolt
Aug 1, 2020·Minerva pediatrica·Sara MantiSalvatore Leonardi
May 26, 2020·Allergologia et immunopathologia·G F ParisiG L Marseglia

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03560466

Software Mentioned

VENTURE

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Immunology and Allergy Clinics of North America
Claus BachertJean Bousquet
American Journal of Respiratory and Critical Care Medicine
Larry Borish
The Journal of Allergy and Clinical Immunology. in Practice
Ahmad R SedaghatMichael J Cunningham
© 2021 Meta ULC. All rights reserved